Article

Dr. Lemack on treatments in development for OAB

In this video, Gary Lemack, MD, offers a brief overview of overactive bladder treatments in development and explains their significance for providers and patients.

Gary Lemack, MD, of UT Southwestern Medical Center in Dallas, co-authored an article in the April 2020 issue of Urology Times® regarding how the development of new pharmacological and device-based treatments could change the management of overactive bladder. In this interview, Dr. Lemack offers a brief overview of treatments in development and explains their significance for providers and patients.

 

Related Videos
Raveen Syan, MD, FPMRS, answers a question during a video interview
Jaspreet S. Sandhu, MD, answers a question during a video interview
J. Quentin Clemens, MD, MSCI, answers a question during a video interview
Timothy Lyon, MD, answers a question during a video interview
Related Content
Desai Sethi Urology Institute shares inaugural Annual Report
January 24th 2025

Desai Sethi Urology Institute shares inaugural Annual Report

University of Miami Health System Desai Sethi Urology Institute
The report, titled "TRANSFORMATION: From an academic department to a leading Institute," highlights DSUI's transformation from a department into a multidisciplinary institute.
Episode 2 Podcast: Managing Overactive Bladder: From Dual Diagnoses to Geriatric Challenges
January 14th 2025

Episode 2 Podcast: Managing Overactive Bladder: From Dual Diagnoses to Geriatric Challenges

Wayne Kuang, MD Steven Maislos, MD
Panelists discuss how managing overactive bladder in older adults requires a holistic approach that integrates treatment of comorbidities, emerging therapeutic options, and quality-of-life considerations to optimize patient outcomes.
Call for Abstract, Workshop, and Roundtable Submissions for PFD Week 2025
January 24th 2025

Call for Abstract, Workshop, and Roundtable Submissions for PFD Week 2025

American Urogynecologic Society
Submit your abstract and/or roundtable and workshop proposal for PFD Week 2025, to be held October 14-17 in Vancouver, Canada!
Episode 1 Podcast: Understanding Overactive Bladder (OAB): Pathophysiology, Diagnosis, and Management in Older Adults
November 27th 2024

Episode 1 Podcast: Understanding Overactive Bladder (OAB): Pathophysiology, Diagnosis, and Management in Older Adults

Wayne Kuang, MD Bilal Chughtai, MD
Experts discuss overactive bladder and the impacts on quality of life, distinguishing OAB from BPH, and how a delayed diagnosis can worsen symptoms.
Take Charge of 2025: A Financial Webinar Series for Physicians
January 24th 2025

Take Charge of 2025: A Financial Webinar Series for Physicians

American Urogynecologic Society
We're excited to announce a new four-part webinar series designed to educate and empower physicians with financial tools and insights needed to prosper in 2025 and beyond.
FDA fast tracks 64Cu-SAR-bisPSMA for biochemically recurrent prostate cancer
January 24th 2025

FDA fast tracks 64Cu-SAR-bisPSMA for biochemically recurrent prostate cancer

Hannah Clarke
64Cu-SAR-bisPSMA was previously granted a fast track designation in August 2024 for PET imaging of PSMA-positive prostate cancer lesions in patients with suspected metastasis who are candidates for initial definitive therapy.
© 2025 MJH Life Sciences

All rights reserved.